Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hyperfine (HYPR) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Hyperfine (HYPR) over the last 6 years, with Q3 2025 value amounting to $21.6 million.

  • Hyperfine's Cash & Equivalents fell 5288.1% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year decrease of 5288.1%. This contributed to the annual value of $37.6 million for FY2024, which is 4992.88% down from last year.
  • Hyperfine's Cash & Equivalents amounted to $21.6 million in Q3 2025, which was down 5288.1% from $25.4 million recorded in Q2 2025.
  • Hyperfine's Cash & Equivalents' 5-year high stood at $188.5 million during Q4 2021, with a 5-year trough of $21.6 million in Q3 2025.
  • Its 5-year average for Cash & Equivalents is $84.9 million, with a median of $77.4 million in 2021.
  • In the last 5 years, Hyperfine's Cash & Equivalents surged by 20074.99% in 2021 and then tumbled by 5288.1% in 2025.
  • Hyperfine's Cash & Equivalents (Quarter) stood at $188.5 million in 2021, then crashed by 37.68% to $117.5 million in 2022, then tumbled by 36.0% to $75.2 million in 2023, then tumbled by 49.93% to $37.6 million in 2024, then tumbled by 42.72% to $21.6 million in 2025.
  • Its Cash & Equivalents was $21.6 million in Q3 2025, compared to $25.4 million in Q2 2025 and $33.1 million in Q1 2025.